These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19006379)

  • 1. Triazine compounds as antagonists at Bv8-prokineticin receptors.
    Balboni G; Lazzari I; Trapella C; Negri L; Lattanzi R; Giannini E; Nicotra A; Melchiorri P; Visentin S; Nuccio CD; Salvadori S
    J Med Chem; 2008 Dec; 51(23):7635-9. PubMed ID: 19006379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triazinediones as prokineticin 1 receptor antagonists. Part 1: SAR, synthesis and biological evaluation.
    Ralbovsky JL; Lisko JG; Palmer JM; Mabus J; Chevalier KM; Schulz MJ; Dyatkin AB; Miskowski TA; Coats SJ; Hornby P; He W
    Bioorg Med Chem Lett; 2009 May; 19(10):2661-3. PubMed ID: 19375913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bv8/Prokineticin proteins and their receptors.
    Negri L; Lattanzi R; Giannini E; Melchiorri P
    Life Sci; 2007 Sep; 81(14):1103-16. PubMed ID: 17881008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bv8/Prokineticins and their Receptors A New Pronociceptive System.
    Negri L; Lattanzi R; Giannini E; Canestrelli M; Nicotra A; Melchiorri P
    Int Rev Neurobiol; 2009; 85():145-57. PubMed ID: 19607967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new convenient synthetic method and preliminary pharmacological characterization of triazinediones as prokineticin receptor antagonists.
    Congiu C; Onnis V; Deplano A; Salvadori S; Marconi V; Maftei D; Negri L; Lattanzi R; Balboni G
    Eur J Med Chem; 2014 Jun; 81():334-40. PubMed ID: 24852280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bv8/PK2 and prokineticin receptors: a druggable pronociceptive system.
    Negri L; Lattanzi R
    Curr Opin Pharmacol; 2012 Feb; 12(1):62-6. PubMed ID: 22136937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2,3,7-Trisubstituted pyrazolo[1,5-d][1,2,4]triazines: functionally selective GABAA alpha3-subtype agonists.
    Carling RW; Russell MG; Moore KW; Mitchinson A; Guiblin A; Smith A; Wafford KA; Marshall G; Atack JR; Street LJ
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3550-4. PubMed ID: 16621541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships of 1,3,5-triazine-2,4,6-triones as human gonadotropin-releasing hormone receptor antagonists.
    Guo Z; Wu D; Zhu YF; Tucci FC; Regan CF; Rowbottom MW; Struthers RS; Xie Q; Reijmers S; Sullivan SK; Sai Y; Chen C
    Bioorg Med Chem Lett; 2005 Aug; 15(16):3685-90. PubMed ID: 15951171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (2-Arylethenyl)-1,3,5-triazin-2-amines as a novel histamine H4 receptor ligands.
    Kamińska K; Ziemba J; Ner J; Schwed JS; Łażewska D; Więcek M; Karcz T; Olejarz A; Latacz G; Kuder K; Kottke T; Zygmunt M; Sapa J; Karolak-Wojciechowska J; Stark H; Kieć-Kononowicz K
    Eur J Med Chem; 2015 Oct; 103():238-51. PubMed ID: 26360048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prokineticin receptors in cardiovascular function: foe or friend?
    Nebigil CG
    Trends Cardiovasc Med; 2009 Feb; 19(2):55-60. PubMed ID: 19577713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and regulation of bv8 in human blood cells.
    Zhong C; Qu X; Tan M; Meng YG; Ferrara N
    Clin Cancer Res; 2009 Apr; 15(8):2675-84. PubMed ID: 19336519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of 1,2,4-methyltriazines as mGluR5 antagonists.
    Olson JP; Gichinga MG; Butala E; Navarro HA; Gilmour BP; Carroll FI
    Org Biomol Chem; 2011 Jun; 9(11):4276-86. PubMed ID: 21503289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and pharmacological characterization of prokineticin 2 beta as a selective ligand for prokineticin receptor 1.
    Chen J; Kuei C; Sutton S; Wilson S; Yu J; Kamme F; Mazur C; Lovenberg T; Liu C
    Mol Pharmacol; 2005 Jun; 67(6):2070-6. PubMed ID: 15772293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The chemokine Bv8/prokineticin 2 is up-regulated in inflammatory granulocytes and modulates inflammatory pain.
    Giannini E; Lattanzi R; Nicotra A; Campese AF; Grazioli P; Screpanti I; Balboni G; Salvadori S; Sacerdote P; Negri L
    Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14646-51. PubMed ID: 19667192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of aryl-1,2,4-triazine-3,5-diones as antagonists of the gonadotropin-releasing hormone receptor.
    Pontillo J; Guo Z; Wu D; Struthers RS; Chen C
    Bioorg Med Chem Lett; 2005 Oct; 15(19):4363-6. PubMed ID: 16046130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and in-vitro pharmacological evaluation of new 5-HT1A receptor ligands containing a benzotriazinone nucleus.
    Fiorino F; Severino B; De Angelis F; Perissutti E; Frecentese F; Massarelli P; Bruni G; Collavoli E; Santagada V; Caliendo G
    Arch Pharm (Weinheim); 2008 Jan; 341(1):20-7. PubMed ID: 18072244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of (3,4-dimethoxyphenoxy)alkylamino acetamides as orexin-2 receptor antagonists.
    Cole AG; Stroke IL; Qin LY; Hussain Z; Simhadri S; Brescia MR; Waksmunski FS; Strohl B; Tellew JE; Williams JP; Saunders J; Appell KC; Henderson I; Webb ML
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5420-3. PubMed ID: 18815029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine properties of prokineticins.
    Monnier J; Samson M
    FEBS J; 2008 Aug; 275(16):4014-21. PubMed ID: 18647349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and pharmacological in vitro and in vivo evaluations of novel triazole derivatives as ligands of the ghrelin receptor. 1.
    Demange L; Boeglin D; Moulin A; Mousseaux D; Ryan J; Bergé G; Gagne D; Heitz A; Perrissoud D; Locatelli V; Torsello A; Galleyrand JC; Fehrentz JA; Martinez J
    J Med Chem; 2007 Apr; 50(8):1939-57. PubMed ID: 17375904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and structure elucidation of novel fused 1,2,4-triazine derivatives as potent inhibitors targeting CYP1A1 activity.
    El Massry AM; Asal AM; Khattab SN; Haiba NS; Awney HA; Helmy M; Langer V; Amer A
    Bioorg Med Chem; 2012 Apr; 20(8):2624-37. PubMed ID: 22414679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.